Smith & Nephew share price rallies after activist investor report

The Duke Of Cambridge Visits The Royal Marsden Chelsea

Smith & Nephew makes orthopaedic implants

The firm earned "Hold" rating on Thursday, October 6 by Berenberg. Comerica Bank now owns 31,542 shares of the medical equipment provider's stock worth $966,000 after buying an additional 608 shares during the last quarter. Morgan Stanley upgraded the shares of SNN in report on Thursday, December 8 to "Overweight" rating. 731,903 shares of the company's stock traded hands.

Investors reacted positively to the prospect of Elliott engineering a shake-up at the firm, pushing its stock up to £14.01 by close. Smith & Nephew plc has a 52 week low of $26.97 and a 52 week high of $35.30.

Smith & Nephew SNATS, Inc. has a 50 day moving average of 36.32 and a 200 day moving average of 34.67. Dynamic Technology Lab Private Ltd now owns 7,694 shares of the medical equipment provider's stock valued at $268,000 after buying an additional 424 shares in the last quarter.

Smith & Nephew PLC (ADR) has a 52 week low of $26.97 and a 52 week high of $40.43 with a P/E ratio of 19.09 The company's market cap is now $0.

The company also recently declared a semiannual dividend, which will be paid on Wednesday, November 1st. On Monday, May 9 the stock rating was upgraded by Jefferies to "Buy". The firm has "Hold" rating by HSBC given on Thursday, January 19. The ex-dividend date is Thursday, October 5th. This represents a yield of 2.42%.

Thomas hopes for CIMB Classic hat-trick
I holed a lot of putts today. "This is a big event but there is no cut so I'm only feeling 50 per cent pressure". The 67 on Thursday marked the 11th time he scored 70 or under in last 13 rounds at the TPC Kuala Lumpur.

Sources with knowledge of the matter told Bloomberg last night that billionaire Paul Singer's hedge fund Elliott Management had built up a stake in Smith & Nephew, without, however, specifying the size of the stake.

"We do not comment on rumour or speculation and we do not comment on the identity of our investors other than those publicly disclosed", Smith & Nephew said in an emailed statement.

02/11/2016 - Smith & Nephew SNATS, Inc. was downgraded to "neutral" by analysts at UBS. Finally, Wetherby Asset Management Inc. raised its position in Smith & Nephew plc by 21.6% in the fourth quarter.

London-listed shares in the company, which makes artificial hips and knees, rose 4.12 per cent to 1,415p this morning.

Wells Fargo & Company MN boosted its position in shares of Smith & Nephew plc (NYSE:SNN) by 21.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The Company's services and products include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies, Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Latest News